1. Home
  2. WSR vs GOSS Comparison

WSR vs GOSS Comparison

Compare WSR & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WSR
  • GOSS
  • Stock Information
  • Founded
  • WSR 1998
  • GOSS 2015
  • Country
  • WSR United States
  • GOSS United States
  • Employees
  • WSR N/A
  • GOSS N/A
  • Industry
  • WSR Real Estate Investment Trusts
  • GOSS Biotechnology: Pharmaceutical Preparations
  • Sector
  • WSR Real Estate
  • GOSS Health Care
  • Exchange
  • WSR Nasdaq
  • GOSS Nasdaq
  • Market Cap
  • WSR 628.6M
  • GOSS 586.6M
  • IPO Year
  • WSR 2010
  • GOSS 2019
  • Fundamental
  • Price
  • WSR $13.16
  • GOSS $2.94
  • Analyst Decision
  • WSR Strong Buy
  • GOSS Strong Buy
  • Analyst Count
  • WSR 2
  • GOSS 4
  • Target Price
  • WSR $15.00
  • GOSS $8.50
  • AVG Volume (30 Days)
  • WSR 192.4K
  • GOSS 3.3M
  • Earning Date
  • WSR 10-29-2025
  • GOSS 11-06-2025
  • Dividend Yield
  • WSR 4.10%
  • GOSS N/A
  • EPS Growth
  • WSR 110.83
  • GOSS N/A
  • EPS
  • WSR 0.66
  • GOSS N/A
  • Revenue
  • WSR $155,373,000.00
  • GOSS $40,237,000.00
  • Revenue This Year
  • WSR $0.98
  • GOSS N/A
  • Revenue Next Year
  • WSR $4.62
  • GOSS $30.65
  • P/E Ratio
  • WSR $20.04
  • GOSS N/A
  • Revenue Growth
  • WSR 5.27
  • GOSS N/A
  • 52 Week Low
  • WSR $11.78
  • GOSS $0.66
  • 52 Week High
  • WSR $15.36
  • GOSS $2.98
  • Technical
  • Relative Strength Index (RSI)
  • WSR 64.39
  • GOSS 76.74
  • Support Level
  • WSR $12.82
  • GOSS $2.41
  • Resistance Level
  • WSR $13.19
  • GOSS $2.71
  • Average True Range (ATR)
  • WSR 0.20
  • GOSS 0.19
  • MACD
  • WSR 0.05
  • GOSS 0.04
  • Stochastic Oscillator
  • WSR 92.91
  • GOSS 96.37

About WSR Whitestone REIT

Whitestone REIT is a real estate investment trust (REIT) engaged in owning and operating commercial properties in culturally diverse markets in metropolitan areas. The company's primary business objective is to increase shareholder value by acquiring, owning, and operating Community Centered Properties. Its property portfolio includes retail and mixed-use properties located in business friendly locations in and around Austin, Chicago, Dallas-Fort Worth, Houston, Phoenix, and San Antonio. The properties are convenience-focused: merchandised with a mix of service-oriented tenants providing food (restaurants and grocers), self-care (health and fitness), services (financial and logistics), education, and entertainment to the surrounding communities.

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Share on Social Networks: